Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chemotherapy and peripheral stem cell transplant with or without monoclonal antibody therapy in Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Commissie Voor Klinisch Toegepast Onderzoek | Conditions: Lymphoma | Phase 3 | Status: COMPLETED